Skip to main content

Table 1 The baseline information of patients with colorectal cancer (CRC) and scoring interferon regulatory factor (IRF) family by random forest algorithm from The Cancer Genome Atlas (TCGA) database of COAD/READ datasets

From: Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer

Patients from COAD/READ All patients
(n = 597)
Low
(n = 298)
High
(n = 299)
P value
Gender     0.904
 Female 277 (46.4%) 139 (46.6%) 138 (46.2%)  
 Male 320 (53.6%) 159 (53.4%) 161 (53.8%)  
Age     0.378
 < 60 170 (28.5%) 80 (26.8%) 90 (30.1%)  
 ≥ 60 427 (71.5%) 218 (73.2%) 209 (69.9%)  
Pathologic stage      < 0.001
 I 108 (18.1%) 69 (23.1%) 39 (13.1%)  
 II 225 (37.7%) 120 (40.3%) 105 (35.1%)  
 III 177 (29.6%) 86 (28.9%) 91 (30.4%)  
 IV 87 (14.6%) 23 (7.7%) 64 (21.4%)  
T     0.002
 T1 19 (3.2%) 11 (3.7%) 8 (2.7%)  
 T2 105 (17.6%) 65 (21.8%) 40 (13.4%)  
 T3 408 (68.3%) 201 (67.5%) 207 (69.2%)  
 T4 65 (10.9%) 21 (7.0%) 44 (14.7%)  
N      < 0.001
 N0 342 (57.3%) 191 (64.1%) 151 (50.6%)  
 N1 145 (24.3%) 71 (23.8%) 74 (24.7%)  
 N2 110 (18.4%) 36 (12.1%) 74 (24.7%)  
M      < 0.001
 M0 453 (75.9%) 249 (83.6%) 204 (68.2%)  
 M1 85 (14.2%) 22 (7.4%) 63 (21.1%)  
 MX 59 (9.9%) 27 (9.0%) 32 (10.7%)